SEARCH

SEARCH BY CITATION

References

  • 1
    Olsson PO, Jorfeldt L, Arnqvist HJ, Gerhardsson P. Pre- and postprandial hyperinsulinemia during insulin pump treatment; role of the subcutaneous bolus and basal infusion. Diabetes Res 1991; 16: 55 61.
  • 2
    Olsson PO, Arnqvist HJ, von Schenck H. Free insulin profiles during subcutaneous insulin regimens in diabetes mellitus type 1. Diabetes Metabolisme 1988; 14: 253 8.
  • 3
    Kang S, Brange J, Burch A, Vølund A, Owens D. Subcutaneous insulin absorption explained by insulin's physicochemical properties: evidence from absorption studies of soluble human insulin and insulin analogues in humans. Diabetes Care 1991; 14: 942 8.
  • 4
    Dimitriadis GD & Gerich JE. Importance of timing of preprandial subcutaneous insulin administration in the management of diabetes mellitus. Diabetes Care 1983; 6: 374 7.
  • 5
    Diabetes and Nutition Study Group of the EASD Recommendations for the nutritional management of patients with diabetes mellitus. Diabetes Nutrition Metabolism 1995; 8: 186 9.
  • 6
    Primavesi R, Drakeford J, Savage DCL. The glycaemic effect of simple sugars in mid-morning and afternoon snacks in childhood diabetes. Eur J Pediatr 1990; 149: 705 8.
  • 7
    Cedermark G, Selenius M, Tullus K. Glycaemic effect and satiating capacity of potato chips and milk chocolate bar as snacks in teenagers with diabetes. Eur J Pediatr 1993; 152: 635 9.
  • 8
    Steel JM, Mitchell D, Prescott RL. Comparison of the glycaemic effect of fructose, sucrose and starch-containing mid-morning snacks in insulin-dependent diabetics. Human Nutrition 1983; 37A: 3 8.
  • 9
    Kuzuya H, Blix PM, Horwitz DL, Steiner DF, Rubinstein AH. Determination of free and total insulin and C-peptide in insulin-treated diabetics. Diabetes 1977; 26: 22 9.
  • 10
    Arnqvist HJ, Olsson PO, von Schenck H. Free and total insulin as determined after precipitation with polyethylene glycol: analytical characteristics and effects of sample handling and storage. Clin Chem 1987; 33: 93 6.
  • 11
    The Diabetes Control and Complications Trial Research Group The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent in insulin-dependent diabetes mellitus. N Engl J Med 1993; 329: 977 86.
  • 12
    Kullberg CE, Bergström A, Dinesen B, Larsson L, Little RR, Arnqvist HJ. Comparisons of studies on diabetic complications hampered by differences in GHb measurements. Diabetes Care 1996; 19: 726 9.
  • 13
    Howey DC, Bowsher RR, Rocco L, Woodworth JR. (Lys(B28), Pro(B29)) – human insulin a rapidly absorbed analogue of human insulin. Diabetes 1994; 43: 396 402.
  • 14
    Bolli GB. The pharmacokinetic of insulin therapy in diabetes mellitus. Diab Res Clin Pract 1989; 6: 3 16.
  • 15
    Woodworth JR, Howey DC, Bowsher RR. Establishment of time-action profiles for regular and NPH insulin using pharmacodynamic modelling. Diabetes Care 1994; 17: 64 9.
  • 16
    Pampanelli S, Torlone E, Lalli C, Del Sindaco P, Ciofetta M, Lepore et al Improved postprandial metabolic control after subcutaneous injection of a short-acting insulin analog in IDDM of short duration with residual pancreatic B-cell function. Diabetes Care 1995; 11: 1452 9.
  • 17
    Kinmonth AL & Baum JD. Timing of pre-breakfast insulin injection and postprandial metabolic control in diabetic children. Br Med J 1980; 280: 604 6.
  • 18
    Olsson PO, Arnqvist HJ, von Schenck H. Miscibility of human semisynthetic regular and lente insulin and human biosynthetic regular and NPH insulin. Diabetes Care 1987; 10: 473 7.
  • 19
    Schernthaner G, Wein W, Sandholzer K, Equiluz-Bruck S, Bates PC, Birkett MA. Postprandial insulin lispro. A new therapeutic option for type 1 diabetic patients. Diabetes Care 1998; 21: 570 3.